Parry Daniel, Baskaran Ravanth, Lima Ashleigh, Dagnan Richard, Jaber Hisham, Manivannan Susruta, Zaben Malik
Department of Respiratory Medicine, University Hospital of Wales, Cardiff and Vale University Health Board, Cardiff, UK.
School of Medicine, Cardiff University, Neuadd Meirionnydd, Cardiff, UK.
Br J Neurosurg. 2025 Apr;39(2):204-209. doi: 10.1080/02688697.2023.2210224. Epub 2023 May 26.
Chronic subdural haematoma (CSDH) is a well-recognized consequence of head injury with a rising incidence worldwide. Whilst symptomatic CSDH warrants consideration of surgical intervention, the management of asymptomatic CSDH (AsCSDH) remains unclear. In this retrospective study, we investigate the natural history of AsCSDH, the requirement for radiological monitoring, and the role of neurosurgical input.
Head injury referrals to a tertiary neurosurgical unit over two years were screened to identify patients with AsCSDH. Clinical, radiological, and outcome parameters were collected for included patients.
Of 2725 referrals, 106 (3.9%) patients were eligible for inclusion. The cohort consisted of predominantly male patients (70.8%) with an average age of 81.9 years and independent at baseline (79.3%). Radiological follow-up was recommended by neurosurgery in 4 patients (3.8%). Medical teams performed follow-up imaging for 57 patients (53.8%) culminating in a total of 116 follow-up scans, predominantly for falls or monitoring purposes. Antithrombotic agents were used by 61 patients (57.5%). Anticoagulants were held in 26/37 patients (70.3%) and antiplatelets in 12/29 patients (41.4%), ranging from 7 to 16 days when specified. Only one patient required neurosurgical intervention at 3 months from the time of initial presentation after the development of symptoms.
Patients with AsCSDH do not require neuroradiological follow-up or neurosurgical intervention in the majority of instances. Medical professionals should explain to patients, families, and caregivers that the isolated finding of CSDH is not necessarily a cause for concern but safety netting advice regarding AsCSDH should be provided.
慢性硬膜下血肿(CSDH)是一种公认的头部损伤后果,在全球范围内发病率呈上升趋势。虽然有症状的CSDH需要考虑手术干预,但无症状CSDH(AsCSDH)的管理仍不明确。在这项回顾性研究中,我们调查了AsCSDH的自然病程、放射学监测的必要性以及神经外科干预的作用。
对两年内转诊至三级神经外科单位的头部损伤患者进行筛查,以确定患有AsCSDH的患者。收集纳入患者的临床、放射学和结局参数。
在2725例转诊患者中,106例(3.9%)符合纳入标准。该队列主要为男性患者(70.8%),平均年龄81.9岁,基线时独立生活(79.3%)。神经外科建议对4例患者(3.8%)进行放射学随访。医疗团队对57例患者(53.8%)进行了随访成像,总共进行了116次随访扫描,主要用于跌倒或监测目的。61例患者(57.5%)使用了抗血栓药物。37例患者中有26例(70.3%)停用了抗凝剂,29例患者中有12例(41.4%)停用了抗血小板药物,停用时间从7天到16天不等(如有具体说明)。从初次出现症状起3个月时,只有1例患者需要神经外科干预。
在大多数情况下,AsCSDH患者不需要神经放射学随访或神经外科干预。医疗专业人员应向患者、家属和护理人员解释,孤立发现的CSDH不一定值得担忧,但应提供有关AsCSDH的安全防护建议。